United States: Puma And The Pitfalls Of The "Narrow" Exclusive License - Axinn Veltrop & Harkrider

Puma Biotechnology is the latest victim of standing requirements in patent cases that continue to wreak havoc on plaintiffs' ability to recover a full measure of damages.